These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3514469)

  • 1. Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patients.
    Rubinstein E; Mark Z; Keren G; Alkan M; Berger S; Bogokowski B
    Infection; 1986; 14 Suppl 1():S20-5. PubMed ID: 3514469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
    Tiengrim S; Phiboonbanakit D; Thunyaharn S; Tantisiriwat W; Santiwatanakul S; Susaengrat W; Srisurat N; Malithong A; Srisangchan P; Thamlikitkul V
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection.
    Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS
    Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.
    Kumada T; Neu HC
    J Antimicrob Chemother; 1985 Nov; 16(5):563-74. PubMed ID: 3865923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic cover during antineoplastic therapy].
    Donno L; Rimoldi R
    Minerva Med; 1973 Apr; 64(27):1438-41. PubMed ID: 4575229
    [No Abstract]   [Full Text] [Related]  

  • 6. [Respiratory tract infections--clinical results with ofloxacin].
    Shah PM; Knothe H
    Infection; 1986; 14 Suppl 1():S79-81. PubMed ID: 3514472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of bacterial infections in the newborn infant.
    Dashefsky B; Klein JO
    Clin Perinatol; 1981 Oct; 8(3):559-77. PubMed ID: 7030577
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gentamicin in pediatrics].
    Careddu P; Rosaschino F
    G Ital Chemioter; 1969; 16(1):233-9. PubMed ID: 4935431
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of trimethoprim on the activity of sulfonamides and antibiotics in experimental infections.
    Grunberg E
    J Infect Dis; 1973 Nov; 128():Suppl:478-85 p. PubMed ID: 4202205
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ofloxacin therapy of difficult-to-treat infections due to multiresistant organisms.
    el-Baz W; Osman L; Abd-el-Hamid T; el-Bokl M; Sabbour MS
    Chemioterapia; 1987 Apr; 6(2):129-33. PubMed ID: 3474079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy results with nalidixic acid in chronic urinary tract infection].
    Broghammer H
    Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373
    [No Abstract]   [Full Text] [Related]  

  • 16. Tobramycin: clinical and microbiological evaluation.
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328
    [No Abstract]   [Full Text] [Related]  

  • 17. [Susceptibilities of clinical isolates to antibacterial agents. Focusing mainly on ofloxacin (first report). Reported by the Research Group for Testing Ofloxacin Susceptibility of Clinical Isolates].
    Kosakai N
    Jpn J Antibiot; 1988 Jan; 41(1):71-104. PubMed ID: 3163383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Choice of antibiotics in infections of the urinary tract].
    Yourassowsky E
    Acta Urol Belg; 1971; 39(4):533-7. PubMed ID: 4950454
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on respiratory infections in primary care clinic (IV). Antibiotic sensitivity of bacteria isolated from patients with respiratory infections visiting 21 private clinics in the Tohoku District of Japan].
    Watanabe A; Ohizumi K; Motomiya M; Matsuno K; Nishino T; Sato R; Hiraga H; Hiraga J; Kodama T; Seki K
    Kansenshogaku Zasshi; 1990 Sep; 64(9):1220-31. PubMed ID: 2243194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.